» Ergoloid Mesylates Capsules contain not less than 90.0 percent and not more than 110.0 percent of the labeled amount of ergoloid mesylates, consisting of not less than 30.3 percent and not more than 36.3 percent of the methane-sulfonate salt of each of the individual alkaloids (dihydroergocristine, dihydroergocornine, and dihydroergocryptine). The ratio of alpha- to beta-dihydroergocryptine mesylate is not less than 1.5:1.0 and not more than 2.5:1.0.